Iodine-131-metaiodobenzylguanidine dosimetry in cancer therapy : Risk versus benefit: Nuclear oncolgy 1996: new horizons for nuclear medicine

Journal article

Peer reviewed

M Tristam, A. S Alaamer, J. S Fleming, V. J Lewington and M. A Zivanovic

The Journal of nuclear medicine (1978), Vol.37(6), pp.1058-1064

1996

Abstract

Biological and medical sciences

Medical sciences

Radiation therapy and radiosensitizing agent

Treatment with physical agents

Treatment. General aspects

Tumors

1 Record Views

Title: Iodine-131-metaiodobenzylguanidine dosimetry in cancer therapy : Risk versus benefit
Creators - without role: M Tristam - Southampton General Hospital
A. S Alaamer - Southampton General Hospital
J. S Fleming - Southampton General Hospital
V. J Lewington - Southampton General Hospital
M. A Zivanovic - Southampton General Hospital
Publication Details: The Journal of nuclear medicine (1978), Vol.37(6), pp.1058-1064
Publisher: Society of Nuclear Medicine
Identifiers: 9916441108331
Academic Unit: Imam Mohammad Ibn Saud Islamic University (IMSIU)
Language: English
Resource Type: Journal article